Altraz (Anastrozole)

Medicine Overview

Altraz contains Anastrozole, an aromatase inhibitor widely prescribed for hormone receptor-positive breast cancer in postmenopausal women. It works by lowering estrogen levels, slowing cancer growth, and reducing the risk of recurrence. Altraz is an essential part of hormone therapy after surgery or chemotherapy, offering effective cancer management with targeted action. Its once-daily dosage ensures convenience and consistent results. Altraz is trusted for its proven ability to improve survival rates and support recovery in breast cancer patients under medical supervision.